HopeStage
Back to all studies
RecruitingNCT07379827

Real-world KarXT use and outcomes in adults with schizophrenia

About this titleRead the official source — NCT07379827
Observational studyAges 18+United States
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
Bryant and 54 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: February 26, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
1,500
Sponsor
Bristol-Myers Squibb
Sponsor type
Pharmaceutical company
Study type
Observational
Intervention type
Medication / drug
Study phase
Not clearly listed
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT07379827
Official title
Show the full official title

Effectiveness and Adverse-effect Switch Evaluation

Recruitment & locations

Currently recruiting

Bryant · Anaheim · Chino

55 more locations
  • La Palma
  • Mission Viejo
  • Oceanside
  • Redlands
  • San Diego
  • Seal Beach
  • Stanford
  • Hartford
  • Bonita Springs
  • Hialeah
  • Homestead
  • Kendall
  • Miami
  • Orange City
  • Orlando
  • Atlanta
  • Austell
  • Marietta
  • Crystal Lake
  • Orland Park
  • Warrenville
  • Hagerstown
  • Worcester
  • Bloomfield Township
  • Detroit
  • Apple Valley
  • Duluth
  • Lincoln
  • Las Vegas
  • Buffalo
  • Monsey
  • Rochester
  • White Plains
  • Cary
  • Charlotte
  • Wilmington
  • Mason
  • Oklahoma City
  • Tulsa
  • Philadelphia
  • State College
  • Wyomissing
  • Cordova
  • Franklin
  • Nashville
  • Austin
  • Dallas
  • Fort Worth
  • Houston
  • Irving
  • McKinney
  • Richmond
  • San Antonio
  • Stafford
  • Petersburg

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Bristol-Myers Squibb, a pharmaceutical company.

Does this study involve medication?

Yes. The study involves medication, including Xanomeline and trospium chloride (KarXT).

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies